Professional Documents
Culture Documents
Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts To 2019
Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts To 2019
Summary
The industry analysis specialist, has released its new report, Toxoplasmosis Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Toxoplasmosis Therapeutics market. The report
identifies the key trends shaping and driving the global Toxoplasmosis Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging
players expected to significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline products within the
global Toxoplasmosis Therapeutics sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by
GlobalDatas team of industry experts.
Scope
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/
The report provides information on the key drivers and challenges of the Toxoplasmosis
Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan)
Toxoplasmosis Therapeutics market revenues data from 2006 to 2011, forecast for eight years
to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Toxoplasmosis
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Toxoplasmosis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Toxoplasmosis Therapeutics
market
Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Toxoplasmosis Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Toxoplasmosis Therapeutics market
in future.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/
Table of Content
2 Toxoplasmosis Therapeutics - Introduction
2.1 Disease Overview
2.1.1 Types of Toxoplasma gondii Strain
2.1.2 Life Cycle and Transmission
2.2 Epidemiology
2.2.1 Historic Epidemiology (20062011)
2.2.2 Forecast Epidemiology (20112019)
2.3 Etiology
2.3.1 Food-borne Transmission
2.3.2 Congenital Transmission
2.3.3 Zoonotic Transmission
2.3.4 Rare Instances of Transmission
2.4 Pathophysiology
2.5 Signs and Symptoms
2.6 Commonly Used Diagnostic Tests
2.6.1 Types of Diagnostic Test
2.7 Treatment and Management Options for Toxoplasmosis
2.7.1 Management of Toxoplasmosis Infection during Gestation
2.7.2 Congenital Toxoplasmosis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/
List Of Tables
Table 1: Toxoplasmosis Therapeutics Market, Global, Prevalence, 2006-2011
Table 2: Toxoplasmosis Therapeutics Market, Global, Prevalence, 2011-2019
Table 3: Alternative Antibiotics Used in Ocular Toxoplasmosis
Table 4: Toxoplasmosis Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 5: Toxoplasmosis Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 6: Toxoplasmosis Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 7: Toxoplasmosis Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 8: Toxoplasmosis Therapeutics Market, France, Revenue ($m), 2006-2011
Table 9: Toxoplasmosis Therapeutics Market, France, Forecast ($m), 2011-2019
Table 10: Toxoplasmosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 11: Toxoplasmosis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 12: Toxoplasmosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 13: Toxoplasmosis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 14: Toxoplasmosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 15: Toxoplasmosis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 16: Toxoplasmosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/
Table 17: Toxoplasmosis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 18: Toxoplasmosis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 19: Toxoplasmosis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 20: Toxoplasmosis Therapeutics-Phase III Pipeline, 2012
Table 21: Toxoplasmosis Therapeutics - Clinical Trials by Country, 2012
Table 22: Toxoplasmosis Therapeutics - Clinical Trials by Phase, 2012
Table 23: Toxoplasmosis Therapeutics - Clinical Trials by Status, 2012
Table 24: Toxoplasmosis Therapeutics - Overall Sponsors, 2012
Table 25: Toxoplasmosis Therapeutics - Prominent Sponsors, 2012
Table 26: Toxoplasmosis Therapeutics - Company Participating in Therapeutics Clinical Trials,
2012
Table 27: Toxoplasmosis-Global, Deals, 2012
Table 28: Toxoplasmosis Therapeutics Market, Global, KOL Insights, 2012
List Of Figures
Figure 1: Diagnosis Algorithm for Congenital Toxoplasmosis
Figure 2: Approaches for the Treatment of Pregnant Women
Figure 3: Toxoplasmosis Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 4: Toxoplasmosis Therapeutics Market, Global, Forecast ($m), 20112019
Figure 5: Toxoplasmosis Therapeutics Market, The US, Forecast ($m), 20062011
Figure 6: Toxoplasmosis Therapeutics Market, The US, Forecast ($m), 20112019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/
Report Price:
Licence Type
Price
$ 3995
Site Licence
$ 7990
$ 11985
Related Reports:
Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to
2019
Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Retinoblastoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/
You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.